Canada · Health Canada Drug Product Database

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)

Source ingredient · 40 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

Canada · Source reference 82472

APO-ESOMEPRAZOLE

Tablet (Delayed-Release) / APOTEX INC

Canada · Source reference 82473

APO-ESOMEPRAZOLE

Tablet (Delayed-Release) / APOTEX INC

Canada · Source reference 106326

APO-ESOMEPRAZOLE DELAYED-RELEASE

Tablet (Delayed-Release) / APOTEX INC

Canada · Source reference 106327

APO-ESOMEPRAZOLE DELAYED-RELEASE

Tablet (Delayed-Release) / APOTEX INC

Canada · Source reference 106722

APO-NAPROXEN / ESOMEPRAZOLE

Tablet (Immediate- And Delayed-Release) / APOTEX INC

Canada · Source reference 106723

APO-NAPROXEN / ESOMEPRAZOLE

Tablet (Immediate- And Delayed-Release) / APOTEX INC

Canada · Source reference 100989

ESOMEPRAZOLE

Tablet (Delayed-Release) / JAMP PHARMA CORPORATION

Canada · Source reference 100990

ESOMEPRAZOLE

Tablet (Delayed-Release) / JAMP PHARMA CORPORATION

Canada · Source reference 102419

ESOMEPRAZOLE

Tablet (Delayed-Release) / SANIS HEALTH INC

Canada · Source reference 87999

ESOMEPRAZOLE

Tablet (Delayed-Release) / PRO DOC LIMITEE

Canada · Source reference 88000

ESOMEPRAZOLE

Tablet (Delayed-Release) / PRO DOC LIMITEE

Canada · Source reference 91561

ESOMEPRAZOLE

Tablet (Delayed-Release) / SANIS HEALTH INC

Canada · Source reference 92285

ESOMEPRAZOLE

Tablet (Delayed-Release) / RANBAXY PHARMACEUTICALS CANADA INC.

Canada · Source reference 92286

ESOMEPRAZOLE

Tablet (Delayed-Release) / RANBAXY PHARMACEUTICALS CANADA INC.

Canada · Source reference 92684

ESOMEPRAZOLE

Tablet (Delayed-Release) / SIVEM PHARMACEUTICALS ULC

Canada · Source reference 92685

ESOMEPRAZOLE

Tablet (Delayed-Release) / SIVEM PHARMACEUTICALS ULC

Canada · Source reference 93541

ESOMEPRAZOLE

Tablet (Delayed-Release) / TEVA CANADA LIMITED

Canada · Source reference 93542

ESOMEPRAZOLE

Tablet (Delayed-Release) / TEVA CANADA LIMITED

Canada · Source reference 100932

M-ESOMEPRAZOLE

Tablet (Delayed-Release) / MANTRA PHARMA INC

Canada · Source reference 100933

M-ESOMEPRAZOLE

Tablet (Delayed-Release) / MANTRA PHARMA INC

Canada · Source reference 97006

MYL-ESOMEPRAZOLE

Tablet (Delayed-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 97007

MYL-ESOMEPRAZOLE

Tablet (Delayed-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 86882

MYLAN-ESOMEPRAZOLE

Tablet (Delayed-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 86883

MYLAN-ESOMEPRAZOLE

Tablet (Delayed-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 89905

MYLAN-ESOMEPRAZOLE

Capsule (Delayed-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 89906

MYLAN-ESOMEPRAZOLE

Capsule (Delayed-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 92813

MYLAN-NAPROXEN/ESOMEPRAZOLE MR

Tablet (Immediate- And Delayed-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 94575

MYLAN-NAPROXEN/ESOMEPRAZOLE MR

Tablet (Immediate- And Delayed-Release) / MYLAN PHARMACEUTICALS ULC

Canada · Source reference 78581

NEXIUM

Granules For Suspension (Delayed-Release / ASTRAZENECA CANADA INC

Canada · Source reference 68498

NEXIUM - 20MG

Tablet (Delayed-Release) / ASTRAZENECA CANADA INC

Browse ingredients in Canada →